| Application no. and date | 19718531.7 (espacenet) (Federated) (European Patent Register), 20190403 | | Patent/reg. no. and date | DK/EP 3773589, 20231101 | | Publication date | 20210217 | | Priority no. and date | US 201862652284 P, 20180403, US 201862656297 P, 20180411, US 201862657605 P, 20180413, US 201862741683 P, 20181005 | | EP pub. no. and date |
EP 3773589 20210217 | | Effective date | | | Applicant/owner | Blueprint Medicines Corporation, 45 Sidney Street
Cambridge, MA 02139, US | | Applicant ref. no. | V470146DK00 | | Inventor | EVANS RAAB, Erica, 45 Sidney Street
Cambridge, Massachusetts 02139, US,
WOLF, Beni B., 45 Sidney Street
Cambridge, Massachusetts 02139, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | RET-inhibitor til anvendelse i behandling af cancer med en RET-ændring | | Int. application no. | US2019025655 | | Int. publication no. | WO2019195471 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
